This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Dec 23;302(24):2657; author reply 2657-8.

doi: 10.1001/jama.2009.1880.

Adverse events and quadrivalent human papillomavirus recombinant vaccine

Vicky Debold, Eric Hurwitz

PMID: 20040547
DOI: 10.1001/jama.2009.1880

Comment

Adverse events and quadrivalent human papillomavirus recombinant vaccine

Vicky Debold et al. JAMA. 2009.

. 2009 Dec 23;302(24):2657; author reply 2657-8.

doi: 10.1001/jama.2009.1880.

Authors

Vicky Debold, Eric Hurwitz

PMID: 20040547
DOI: 10.1001/jama.2009.1880

No abstract available

PubMed Disclaimer

Comment on

Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine.
Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, Markowitz LE, Iskander J. Slade BA, et al. JAMA. 2009 Aug 19;302(7):750-7. doi: 10.1001/jama.2009.1201. JAMA. 2009. PMID: 19690307

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems